• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » More deals ahead for Covidien? | Wall Street Beat

More deals ahead for Covidien? | Wall Street Beat

May 2, 2012 By MassDevice staff

MassDevice.com Wall Street Beat

As Covidien (NYSE:COV) closed its 4th recent acquisition, analysts speculated that there may be more deals on the near future.

The Mansfield, Mass.-based company may be looking to pick up some assets in hypertension treatment, or may keep its sights on additional acquisitions in Israel.

A report by MedCity News speculated that Covidien’s support for Maya Medical’s renal denervation systems may soon lead to a buyout.

An unnamed investor told Israel’s Globes business news that Covidien will likely be on the lookout for "activities in their existing areas or areas in which their major competitors are not operating."

That may include pulmonary devices, anesthetics intensive care and monitoring, the investor added.

Covidien picked up 3 Israeli device makers on its recent shopping spree. The company spent spent $300 million for patient monitoring device maker Oridion (SWF:ORIDN), $300 million plus possible earnouts for superDimension and an undisclosed amount for hernia mesh maker PolyTouch Medical Ltd.

Covidien this week also closed the $108 million acquisition of Newport Medical Instruments, a deal initially announced in March.

 Regulatory, economic uncertainty driving slowdown in hospital capital spending, analysis says
A decreasing percentage of survey respondents reported that their hospital capital budgets had increased or remained flat for 2012, with most attributing the cuts to reductions in reimbursement and debt concerns, according to a survey conducted by the group purchasing organization Premier Healthcare Alliance.
 Read more

 Medic Vision, BRIT Systems sign U.S. deal for SafeCT
Texas-based BRIT Systems signed a deal to support U.S. sales of Israel-based Medic Vision Imaging Solutions’ SafeCT image enhancement system.  Read more

 ConvaTec buys AbViser Medical for an undisclosed amount
Skillman, N.J.-based ConvaTec acquired AbViser Medical LLC, maker of the AbViser intra-abdominal pressure monitoring system. The terms of the deal were not make public. Read more

 Corpak acquires Micronix’s assets
Buffalo Grove, Ill.-based Corpak picked up all the intellectual property and other assets of Micronix for an undisclosed amount.  Read more

 Synexus nabs Osteomed, terms not disclosed
Manchester, U.K.-based Synexus purchased Poland’s Osteomed for an undisclosed amount.  Read more

 HCL Technologies and Becton Dickinson join forces for R&D

Indian HCL Technologies announced an engineering and R&D partnership with Becton Dickinson & Co. (NYSE:BDX). The terms of the deal were not made public.  Read more

 EndoEvolution licenses MIS suturing device to Edwards Lifesciences’

Chelmsford, Mass.-based EndoEvolution signed an exclusive worldwide agreement to license its Endo360 deg MIS suturing device to Edwards Lifesciences’ (NYSE:EW) for cardiac-related applications only. Read more

 Teleflex hits 52-week high
Teleflex (NYSE:TFX) notched a new 52-week high yesterday, opening at $64.79 per share before closing at $63.66. Shares jumped after the medical device maker revealed a pair of acquisitions and earnings well above Wall Street’s expectations.

 GPOs: Novation touts new distribution agreements
Group purchasing organization Novation signed distribution agreements with a clutch of companies, including Cardinal Health, Medline Industries and Owens & Minor Distribution, as well as to several regional distributors.  Read more

 Funding Roundup

  • Solta Medical prices $75M offering of stock, warrants and securities
  • Henry Shein announces new $200M private placement shelf agreement with MetLife
  • InHealth doles out more than $440k in med-tech grants to Mass. General Hospital and the Mount Sinai School of Medicine

 Analysts’ ups and downs

  • Becton Dickinson & Co. (NYSE:BDX): Deutsche cuts price target from $82 to $81 on low organic growth
  • Biogen Idec (NSDQ:BIIB): Jeffries raises price target from $137 to $154
  • Edwards Lifesciences (NYSE:EW): Goldman Sachs maintains "buy" rating, raises price target from $90 to $97; Wells Fargo upgrades to "outperform" rating on Sapien sales and reimbursement outlook; Cannacord Genuity maintains "buy" rating, raises price target fro $86 to $93; Leerink Swann maintain "outperform" rating and $90 price target
  • Haemonetics (NYSE:HAE): Morgan Stanley raises to "equal weight" rating, maintains $55 price target
  • Hologic (NSDQ:HOLX): Cantor Fitzgerald maintains "hold" rating, boost price target from $18 to $20
  • Hospira (NYSE:HSP): Leerink Swann hand down "market perform" rating, $36 price target
  • Medidata NSDQ:MDSO): Jeffries maintains "buy" rating, increases price target from $31 to $34
  • NuVasive Inc. (NSDQ:NUVA): Baird ups rating to "outperform," raises price target from $18 to $24; William Blair lifts rating to "outperform"; Cannacord Genuity maintains "buy" rating, increases price target from $21 to $27
  • Solta Medical (NSDQ:SLTM): Leerink Swann hands down "outperform" rating, raises price target from $4.12 to $4.95
  • Spectranetics (NSDQ:SPNC): Barrington Research maintains an "outperform" rating and $13 price target
  • Teleflex (NYSE:TFX): Jeffries raises price target to $64, maintains "hold" rating; Leerink Swann maintains "market perform" rating
  • Thoratec (NSDQ:THOR): Oppenheimer & Co. maintains "outperform rating," raises price target from $40 to $42; Leerink Swann maintains "outperform" rating and $45 price target
  • Wright Medical (NSDQ:WMGI): Jeffries raises price target to to $19, upgrades to "hold" rating

Filed Under: Funding Roundup, Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: AbViser, becton dickinson, BRIT Systems, ConvaTec, Corpak Medsystems Inc., Covidien, Deals Roundup, Edwards Lifesciences, EndoEvolution LLC, HCL Technologies, Henry Schein Inc., InHealth, Medic Vision Imaging Solutions, Newport Medical Instruments, Osteomed, Premier Inc., Solta Medical Inc., Synexus, Teleflex

More recent news

  • GE HealthCare expands digital imaging portfolio with enhanced MIM Encore software
  • Accelus wins FDA clearance for MRI compatibility of FlareHawk spinal implants
  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech
  • Neurent Medical wins FDA nod for next-gen chronic rhinitis treatment

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy